{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:58:06Z","timestamp":1792695486356,"version":"4.5.0"},"reference-count":36,"publisher":"China Science Publishing & Media Ltd.","issue":"3","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/abbs\/gmy006","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T12:07:19Z","timestamp":1516622839000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":81,"title":["MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation"],"prefix":"10.3724","volume":"50","author":[{"given":"Zhongqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jbmr.262","volume":"26","author":"Kida S","year":"2011","unstructured":"Kida S. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?. J Bone Miner Res, 2011, 26:","journal-title":"J Bone Miner Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","volume":"19","author":"Kanis JA","year":"2008","unstructured":"Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int, 2008, 19: 399-428.","journal-title":"Osteoporos Int"},{"key":"null","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.7717\/peerj.971","volume":"3","author":"Jia M","year":"2015","unstructured":"Jia M, Zhang D, Pan N, Ning S, Wang Q, Fan J, Ping Z. Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis. Peer J, 2015, 3:","journal-title":"Peer J"},{"key":"null","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1377\/hlthaff.2012.0535","volume":"31","author":"Feng Z","year":"2012","unstructured":"Feng Z, Liu C, Guan X, Mor V. China\u2019s rapidly aging population creates policy challenges in shaping a viable long-term care system. Health Aff (Millwood), 2012, 31:","journal-title":"Health Aff (Millwood)"},{"key":"null","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/SMJ.0b013e3182a0df8b","volume":"106","author":"Sanders S","year":"2013","unstructured":"Sanders S, Geraci SA. Osteoporosis in postmenopausal women: considerations in prevention and treatment: (women\u2019s health series). South Med J, 2013, 106: 698-706.","journal-title":"South Med J"},{"key":"null","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","volume":"142","author":"Tella SH","year":"2014","unstructured":"Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem, 2014, 142:","journal-title":"J Steroid Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1182\/blood-2010-10-311415","volume":"117","author":"Sugatani T","year":"2011","unstructured":"Sugatani T, Vacher J, Hruska KA. A microRNA expression signature of osteoclastogenesis. Blood, 2011, 117:","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcb.22228","volume":"109","author":"Mizoguchi F","year":"2010","unstructured":"Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, Nakamura T, Kato S. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem, 2010, 109: 866-875.","journal-title":"J Cell Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1074\/jbc.M805777200","volume":"284","author":"Sugatani T","year":"2009","unstructured":"Sugatani T, Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem, 2009, 284:","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1093\/hmg\/dds129","volume":"21","author":"Bae Y","year":"2012","unstructured":"Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T, Dawson BC. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet, 2012, 21:","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jre.12017","volume":"48","author":"Kagiya T","year":"2013","unstructured":"Kagiya T, Nakamura S. Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J Periodontal Res, 2013, 48:","journal-title":"J Periodontal Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"e34641","DOI":"10.1371\/journal.pone.0034641","volume":"7","author":"Wang Y","year":"2012","unstructured":"Wang Y, Li L, Moore BT, Peng XH, Fang X, Lappe JM, Recker RR. MiR-133a in human circulating monocytes: A potential biomarker associated with postmenopausal osteoporosis. PLoS One, 2012, 7:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/1354750X.2014.935957","volume":"19","author":"Li H","year":"2014","unstructured":"Li H, Wang Z, Fu Q, Zhang J. Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients. Biomarkers, 2014, 19:","journal-title":"Biomarkers"},{"key":"null","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4314\/tjpr.v16i3.20","volume":"16","author":"Chen H","year":"2017","unstructured":"Chen H, Jiang H, Dan C, Xu H, Zhang K, Guo S. Evaluation of MicroRNA 125b as a potential biomarker for postmenopausal osteoporosis. Trop J Pharm Res, 2017, 16:","journal-title":"Trop J Pharm Res"},{"key":"null","first-page":"1","volume":"843","author":"Organization WH","year":"1994","unstructured":"Organization WH. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser, 1994, 843: 1-129.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"null","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","volume":"15","author":"Kalu DN","year":"1991","unstructured":"Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner, 1991, 15:","journal-title":"Bone Miner"},{"key":"null","doi-asserted-by":"crossref","first-page":"E1132","DOI":"10.1097\/BRS.0000000000000488","volume":"39","author":"Cuellar JM","year":"2014","unstructured":"Cuellar JM, Yoo A, Tovar N, Coelho PG, Jimbo R, Vandeweghe S, Kirsch T. The effects of Amicar and TXA on lumbar spine fusion in an animal model. Spine, 2014, 39:","journal-title":"Spine"},{"key":"null","first-page":"1159","volume":"8","author":"Lin JT","year":"2007","unstructured":"Lin JT, Tie WU, Cui L, Qiong YU, Guo Z, Chen ZD. The effect of YPF extract on morphometry of bone in model rats with osteoporosis which induced by cyclophosphamide. Liaoning J Tradit Chin Med, 2007, 8: 1159-1161.","journal-title":"Liaoning J Tradit Chin Med"},{"key":"null","unstructured":"Baron R, Vignery A, Neff L, Silverglate A, Maria AS, Baron R, Vignery A,, et al.. Processing of undecalcified bone specimens for bone histomorphometry. Bone Histomorphometry Teachniques & Interpretation 1983."},{"key":"null","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1073\/pnas.1018493108","volume":"108","author":"Zhang Y","year":"2011","unstructured":"Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA, 2011, 108: 9863-9868.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2010.11.079","volume":"404","author":"Zhou Q","year":"2011","unstructured":"Zhou Q, Zhao ZN, Cheng JT, Zhang B, Xu J, Huang F, Zhao RN. Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs. Biochem Biophys Res Commun, 2011, 404: 127-132.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","first-page":"1527","volume":"21","author":"Lv H","year":"2014","unstructured":"Lv H, Sun Y, Zhang Y. MiR-133 is involved in estrogen deficiency-induced osteoporosis through modulating osteogenic differentiation of mesenchymal stem cells. Med Sci Monit, 2014, 21: 1527-1534.","journal-title":"Med Sci Monit"},{"key":"null","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3904\/kjim.2010.25.1.93","volume":"25","author":"Lee EG","year":"2010","unstructured":"Lee EG, Yun HJ, Lee SI, Yoo WH. Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1\u03b2-stimulated osteoclast differentiation through downregulation of MAPKs, c-Fos and NFATc1. Korean J Intern Med, 2010, 25: 93-100.","journal-title":"Korean J Intern Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"Teitelbaum SL","year":"2003","unstructured":"Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Gene, 2003, 4: 638-649.","journal-title":"Nat Rev Gene"},{"key":"null","doi-asserted-by":"crossref","first-page":"e59171","DOI":"10.1371\/journal.pone.0059171","volume":"8","author":"Wei ZF","year":"2013","unstructured":"Wei ZF, Tong B, Xia YF, Lu Q, Chou GX, Wang ZT, Dai Y. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs\/NF-\u03baB\/c-Fos\/NFATc1 pathways. PLoS One, 2013, 8:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1074\/jbc.M609723200","volume":"282","author":"Sharma SM","year":"2007","unstructured":"Sharma SM, Agnieszka B, Rong H, Krupen P, Mansky KC, Said S, Ostrowski MC. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem, 2007, 282: 15921-15929.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.fct.2012.02.019","volume":"50","author":"Cheng B","year":"2012","unstructured":"Cheng B, Li J, Du J, Xiang L, Li W, Ling C. Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-\u03baB and MAPKs pathways. Food Chem Toxicol, 2012, 50: 1610-1615.","journal-title":"Food Chem Toxicol"},{"key":"null","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/annrheumdis-2011-201230.36","volume":"71","author":"Harvey BP","year":"2012","unstructured":"Harvey BP, Syed F, Kaymakcalan Z. THU0028\u2005Fibroblast-like synoviocytes inhibit TNF- and RANKL-induced human osteoclast precursor differentiation following exposure to IL-1BETA. Ann Rheum Dis, 2012, 71: 162-163.","journal-title":"Ann Rheum Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2004.02.001","volume":"26","author":"Ma T","year":"2004","unstructured":"Ma T, Miyanishi K, Suen A, Epstein NJ, Tomita T, Smith RL, Goodman SB. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha. Cytokine, 2004, 26: 138-144.","journal-title":"Cytokine"},{"key":"null","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10408360801949442","volume":"45","author":"Vasikaran SD","year":"2008","unstructured":"Vasikaran SD. Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Crit Rev Clin Lab Sci, 2008, 45: 221-258.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/pmj.78.926.727","volume":"78","author":"Dogan E","year":"2002","unstructured":"Dogan E, Posaci C. Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women. Postgrad Med J, 2002, 78: 727-731.","journal-title":"Postgrad Med J"},{"key":"null","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","volume":"20","author":"Suda T","year":"1999","unstructured":"Suda T, Takahashi N, Jimi N, Gillespie E, Martin M.T. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev, 1999, 20: 345-357.","journal-title":"Endocr Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"Hofbauer LC","year":"2000","unstructured":"Hofbauer LC, Sundeep K, Dunstan CR, Lacey DL, Boyle WJ, Lawrence RB. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res, 2000, 15: 2-12.","journal-title":"J Bone Miner Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0169-6009(91)90086-F","volume":"14","author":"Compston JE","year":"1991","unstructured":"Compston JE, Croucher PI. Histomorphometric assessment of trabecular bone remodelling in osteoporosis. Bone Miner, 1991, 14: 91-102.","journal-title":"Bone Miner"},{"key":"null","first-page":"70","volume":"27","author":"Peel N","year":"2009","unstructured":"Peel N. Bone remodelling and disorders of bone metabolism. Surgery, 2009, 27: 70-74.","journal-title":"Surgery"},{"key":"null","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.bone.2008.07.002","volume":"43","author":"Tanaka M","year":"2008","unstructured":"Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K. Long-term minodronic acid (ONO-5920\/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia. Bone, 2008, 43: 894-900.","journal-title":"Bone"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/9375B0394DE648B49C099C1370E46F0E","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy006","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/9375B0394DE648B49C099C1370E46F0E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T17:20:40Z","timestamp":1719768040000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,1]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmy006","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,1]]}}}